VANCOUVER, BC — February 11, 2026 — Leads & Copy —
Eshbal Functional Food Inc. (TSXV: ESBL) has announced the first closing of its non-brokered private placement. The company closed an initial tranche of 4,245,117 units, generating gross proceeds of $721,670.
Each unit consists of one common share of the company and one common share purchase warrant. Each warrant allows the holder to buy one additional common share at an exercise price of $0.30 until February 10, 2028. All securities issued under the offering have resale restrictions until June 11, 2026, as per securities laws.
The company will use the proceeds to advance acquisition opportunities identified within the gluten-free industry. Funds will also support ongoing product developments, projects, and working capital. Eshbal paid $10,721 and issued 63,070 warrants to Haywood Securities Inc. in connection with the offering.
Eshbal may complete additional closings of the offering.
According to Tomer Bar Meir, CEO of Eshbal, the company is in talks with several companies to support its strategy in the artisanal gluten-free industry. He said that the proceeds from the private placement will help accelerate this strategy to drive the scale and manufacturing efficiencies needed by mainstream grocers.
Eshbal Functional Food focuses on the gluten-free and “Better for You” categories. The company is pursuing a roll-up strategy in the fragmented, artisanal gluten-free market to create a platform that delivers the scale needed by mainstream grocers. Eshbal’s recent agreement with Dare 2 be Different Foods provides potential distribution in Walmart and over 300 other stores in the Northeast USA.
Neither the TSX Venture Exchange Inc. nor its Regulation Service provider accepts responsibility for the adequacy or accuracy of this release.
Source: Eshbal Functional Food
